Asset Details
Do you wish to reserve the book?
Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
Do you wish to request the book?
Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
2020
Overview
The high affinity and specificity of peptides towards biological targets, in addition to their favorable pharmacological properties, has encouraged the development of many peptide-based pharmaceuticals, including peptide-based positron emission tomography (PET) radiopharmaceuticals. However, the poor in vivo stability of unmodified peptides against proteolysis is a major challenge that must be overcome, as it can result in an impractically short in vivo biological half-life and a subsequently poor bioavailability when used in imaging and therapeutic applications. Consequently, many biologically and pharmacologically interesting peptide-based drugs may never see application. A potential way to overcome this is using peptide analogues designed to mimic the pharmacophore of a native peptide while also containing unnatural modifications that act to maintain or improve the pharmacological properties. This review explores strategies that have been developed to increase the metabolic stability of peptide-based pharmaceuticals. It includes modifications of the C- and/or N-termini, introduction of d- or other unnatural amino acids, backbone modification, PEGylation and alkyl chain incorporation, cyclization and peptide bond substitution, and where those strategies have been, or could be, applied to PET peptide-based radiopharmaceuticals.
Publisher
MDPI AG,MDPI
Subject
/ Animals
/ Carbon Radioisotopes - chemistry
/ Carbon Radioisotopes - pharmacokinetics
/ Drugs
/ Fluorine Radioisotopes - chemistry
/ Fluorine Radioisotopes - pharmacokinetics
/ Gallium Radioisotopes - chemistry
/ Gallium Radioisotopes - pharmacokinetics
/ Humans
/ Peptides
/ Peptides - chemical synthesis
/ Peptidomimetics - chemical synthesis
/ Peptidomimetics - pharmacokinetics
/ positron emission tomography
/ Positron-Emission Tomography - methods
/ Protein Processing, Post-Translational
/ Proteins
/ Radiopharmaceuticals - chemical synthesis
/ Radiopharmaceuticals - pharmacokinetics
/ Review
/ Rodentia
/ Tumors
